Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-035179
Filing Date
2011-06-17
Accepted
2011-06-17 12:39:21
Documents
1
Period of Report
2011-06-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c18889_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c18889_4x0.xml 4 6156
  Complete submission text file 0001209191-11-035179.txt   7680
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HALOZYME THERAPEUTICS, INC. 11588 SORRENTO VALLEY ROAD, #17 SAN DIEGO CA 92121
Business Address
RAMSAY DAVID A (Reporting) CIK: 0001283292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 11917822